We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current AMGN market cap is 144.12B. The company's latest EPS is USD 12.5336 and P/E is 21.46.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 6.65B | 6.84B | 6.11B | 6.99B | 6.9B |
| Operating Income | 2.67B | 1.69B | 3.79B | 2.68B | 2.02B |
| Net Income | 2.14B | 1.62B | 2.84B | 1.38B | 1.73B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 23.36B | 25.42B | 25.98B | 26.32B | 28.19B |
| Operating Income | 9.67B | 9.14B | 7.64B | 9.57B | 9.35B |
| Net Income | 7.84B | 7.26B | 5.89B | 6.55B | 6.72B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 63.7B | 65.12B | 88.72B | 90.27B | 90.53B |
| Total Liabilities | 60.05B | 61.46B | 83.37B | 83.49B | 82.88B |
| Total Equity | 3.65B | 3.66B | 5.35B | 6.78B | 7.66B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 59.71B | 62.95B | 61.17B | 65.12B | 97.15B |
| Total Liabilities | 50.03B | 53.54B | 54.47B | 61.46B | 90.92B |
| Total Equity | 9.67B | 9.41B | 6.7B | 3.66B | 6.23B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 7.07B | 9.72B | 1.06B | 5.17B | 7.93B |
| Investing | -2.57B | -6.04B | 1.36B | 1.15B | 885M |
| Financing | -2.99B | -4.04B | 21.51B | 20.3B | 18.29B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 9.15B | 10.5B | 9.26B | 9.72B | 8.47B |
| Investing | 5.71B | -5.4B | 733M | -6.04B | -26.2B |
| Financing | -15.77B | -4.87B | -8.27B | -4.04B | 21.05B |
| Market Cap | 144.12B |
| Price to Earnings Ratio | 21.46 |
| Price to Sales Ratio | 5.11 |
| Price to Cash Ratio | 13.17 |
| Price to Book Ratio | 23.13 |
| Dividend Yield | 3.26% |
| Shares Outstanding | 535.92M |
| Average Volume (1 week) | 2.03M |
| Average Volume (1 Month) | 2.19M |
| 52 Week Change | 9.15% |
| 52 Week High | 329.72 |
| 52 Week Low | 211.73 |
| Spread (Intraday) | 4.9 (1.81%) |
| Company Name | Amgen Inc |
| Address |
251 little falls drive wilmington, delaware 19808 |
| Website | https://www.amgen.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
